Central Pharmaceuticals Ltd. reported unaudited earnings results for the third quarter and nine months ended March 31, 2018. For the quarter, the company reported EPS of BDT 0.14 compared to BDT 0.33 a year ago. For the nine months, the company reported EPS of BDT 0.29 compared to BDT 0.99 a year ago. NOCFPS was BDT 0.02 compared to BDT 0.12 a year ago. NAV per share was BDT 15.55 as of March 31, 2018.